Your browser doesn't support javascript.
loading
United States' regulatory approved pharmacotherapies for nuclear reactor explosions and anthrax-associated bioterrorism.
Bennett, Charles L; Georgantopoulos, Peter; Gale, Robert Peter; Knopf, Kevin; Hrushesky, William J; Nabhan, Chadi; Armitage, James O.
Afiliación
  • Bennett CL; The SmartState Center for Medication Safety and Efficacy and the Department of Family Medicine, the University of South Carolina, Columbia, South Carolina, (CLB, PG, KK, CN, WJH), the City of Hope National Cancer Institute Designated Comprehensive Cancer Center, Duarte, California (CLB, SJR), Imperi
  • Georgantopoulos P; The SmartState Center for Medication Safety and Efficacy and the Department of Family Medicine, the University of South Carolina, Columbia, South Carolina, (CLB, PG, KK, CN, WJH), the City of Hope National Cancer Institute Designated Comprehensive Cancer Center, Duarte, California (CLB, SJR), Imperi
  • Gale RP; The SmartState Center for Medication Safety and Efficacy and the Department of Family Medicine, the University of South Carolina, Columbia, South Carolina, (CLB, PG, KK, CN, WJH), the City of Hope National Cancer Institute Designated Comprehensive Cancer Center, Duarte, California (CLB, SJR), Imperi
  • Knopf K; The SmartState Center for Medication Safety and Efficacy and the Department of Family Medicine, the University of South Carolina, Columbia, South Carolina, (CLB, PG, KK, CN, WJH), the City of Hope National Cancer Institute Designated Comprehensive Cancer Center, Duarte, California (CLB, SJR), Imperi
  • Hrushesky WJ; The SmartState Center for Medication Safety and Efficacy and the Department of Family Medicine, the University of South Carolina, Columbia, South Carolina, (CLB, PG, KK, CN, WJH), the City of Hope National Cancer Institute Designated Comprehensive Cancer Center, Duarte, California (CLB, SJR), Imperi
  • Nabhan C; The SmartState Center for Medication Safety and Efficacy and the Department of Family Medicine, the University of South Carolina, Columbia, South Carolina, (CLB, PG, KK, CN, WJH), the City of Hope National Cancer Institute Designated Comprehensive Cancer Center, Duarte, California (CLB, SJR), Imperi
  • Armitage JO; The SmartState Center for Medication Safety and Efficacy and the Department of Family Medicine, the University of South Carolina, Columbia, South Carolina, (CLB, PG, KK, CN, WJH), the City of Hope National Cancer Institute Designated Comprehensive Cancer Center, Duarte, California (CLB, SJR), Imperi
Expert Opin Drug Saf ; 22(9): 783-788, 2023.
Article en En | MEDLINE | ID: mdl-37594915
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bacillus anthracis / Vacunas contra el Carbunco / Síndrome de Radiación Aguda / Carbunco Tipo de estudio: Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Expert Opin Drug Saf Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bacillus anthracis / Vacunas contra el Carbunco / Síndrome de Radiación Aguda / Carbunco Tipo de estudio: Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Expert Opin Drug Saf Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article